bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplemental Figures 1-3 from The Alarmin HMGN1 Contributes to Antitumor Immunity and Is a Potent Immunoadjuvant
Authors: Wei Feng , Yang De , Tewary Poonam , Li Yana , Li Sandra , Chen Xin , Howard O.M. Zack , Bustin Michael , Oppenheim Joost J.
Published: April 2023

Supplemental Figures 1-3. sFig. 1: Uppregulation of DC CD80, CD86, and I-A/E in response to HMGN1. sFig. 2: Comparison of in vitro proliferation and in vivo tumor generation of control and HMGN1-expressing EL4 tumor cells. sFig. 3: Analysis gating strategy for determination of IFNγ-producing CD8 T cells.
Supplementary Figure Legends from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
Authors: Lallet-Daher Hélène , Wiel Clotilde , Gitenay Delphine , Navaratnam Naveenan , Augert Arnaud , Le Calvé Benjamin , Verbeke Stéphanie , Carling David , Aubert Sébastien , Vindrieux David , Bernard David
Published: April 2023

PDF - 73KB, Legends for Supplementary Figures.
Supplementary Figure 9 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
Authors: Lallet-Daher Hélène , Wiel Clotilde , Gitenay Delphine , Navaratnam Naveenan , Augert Arnaud , Le Calvé Benjamin , Verbeke Stéphanie , Carling David , Aubert Sébastien , Vindrieux David , Bernard David
Published: April 2023

PDF - 429K, KCNA1 expression in different breast cancer subgroups.
Supplementary Figures 1 - 7 from Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma
Authors: Yan Fengting , Alinari Lapo , Lustberg Mark E. , Katherine Martin Ludmila , Cordero-Nieves Hector M. , Banasavadi-Siddegowda Yeshavanth , Virk Selene , Barnholtz-Sloan Jill , Bell Erica Hlavin , Wojton Jeffrey , Jacob Naduparambil K. , Chakravarti Arnab , Nowicki Michal O. , Wu Xin , Lapalombella Rosa , Datta Jharna , Yu Bo , Gordon Kate , Haseley Amy , Patton John T. , Smith Porsha L. , Ryu John , Zhang Xiaoli , Mo Xiaokui , Marcucci Guido , Nuovo Gerard , Kwon Chang-Hyuk , Byrd John C. , Chiocca E. Antonio , Li Chenglong , Sif Said , Jacob Samson , Lawler Sean , Kaur Balveen , Baiocchi Robert A.
Published: April 2023

PDF file - 1690KB, Supplemental Figure S1. PRMT5 is over-expressed in human GBM cell lines. Supplemental Figure S2: High grade astrocytomas Supplemental Figure S3: efficacy and specificity of PRMT5 knock-down by lead siRNA. Supplemental Figure S4: PRMT5 Knockdown promotes cell death of human GBM cells Supplemental Figure S5: si-PRMT5 induced cell death is P53-independent Supplemental Figure S6: Decreased ST7 expression correlates with worse survival in all glioma patients (grade I-IV). Supplemental Figure S7: Over-expression of ST7 in three GBM cell lines was confirmed by real-time PCR and western blot (top panels).
Supplementary Materials and Methods, Figure Legends, Tables 1 - 5 from NDY1/KDM2B Functions as a Master Regulator of Polycomb Complexes and Controls Self-Renewal of Breast Cancer Stem Cells
Authors: Kottakis Filippos , Foltopoulou Parthena , Sanidas Ioannis , Keller Patricia , Wronski Ania , Dake Benjamin T. , Ezell Scott A. , Shen Zhu , Naber Stephen P. , Hinds Philip W. , McNiel Elizabeth , Kuperwasser Charlotte , Tsichlis Philip N.
Published: April 2023

PDF file - 154KB, Table S1. Cell lines, media. Table S2. Pre-miRs and anti-miRs. Table S3. Primers. Table S4. Antibodies. Table S5. Clinical characteristics of the tumor-samples used in Figure 7.
Supplementary Figure 6 from NDY1/KDM2B Functions as a Master Regulator of Polycomb Complexes and Controls Self-Renewal of Breast Cancer Stem Cells
Authors: Kottakis Filippos , Foltopoulou Parthena , Sanidas Ioannis , Keller Patricia , Wronski Ania , Dake Benjamin T. , Ezell Scott A. , Shen Zhu , Naber Stephen P. , Hinds Philip W. , McNiel Elizabeth , Kuperwasser Charlotte , Tsichlis Philip N.
Published: April 2023

PDF file - 59KB, The knockdown of NDY1/KDM2B suppresses the activity of the Wnt pathway, despite the upregulation of Wnt1.
Supplementary Table and Figure Legends from HMGB1 Enhances Immune Suppression by Facilitating the Differentiation and Suppressive Activity of Myeloid-Derived Suppressor Cells
Authors: Parker Katherine H. , Sinha Pratima , Horn Lucas A. , Clements Virginia K. , Yang Huan , Li Jianhua , Tracey Kevin J. , Ostrand-Rosenberg Suzanne
Published: April 2023

Supplementary Table and Figure Legends. Legend for Supplementary Tables S1-S2 and Supplementary Figures S1-S4.
Supplementary Figure 1 from NDY1/KDM2B Functions as a Master Regulator of Polycomb Complexes and Controls Self-Renewal of Breast Cancer Stem Cells
Authors: Kottakis Filippos , Foltopoulou Parthena , Sanidas Ioannis , Keller Patricia , Wronski Ania , Dake Benjamin T. , Ezell Scott A. , Shen Zhu , Naber Stephen P. , Hinds Philip W. , McNiel Elizabeth , Kuperwasser Charlotte , Tsichlis Philip N.
Published: April 2023

PDF file - 78KB, The NDY1/KDM2B knockdown inhibits anchorage-dependent and independent growth of cancer cells.
Supplementary Figure Legend from Activation of the NOTCH Pathway in Head and Neck Cancer
Authors: Sun Wenyue , Gaykalova Daria A. , Ochs Michael F. , Mambo Elizabeth , Arnaoutakis Demetri , Liu Yan , Loyo Myriam , Agrawal Nishant , Howard Jason , Li Ryan , Ahn Sun , Fertig Elana , Sidransky David , Houghton Jeffery , Buddavarapu Kalyan , Sanford Tiffany , Choudhary Ashish , Darden Will , Adai Alex , Latham Gary , Bishop Justin , Sharma Rajni , Westra William H. , Hennessey Patrick , Chung Christine H. , Califano Joseph A.
Published: April 2023

PDF file - 116K
Supplementary Figure Legend from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression through Misregulation of LCN2
Authors: Cheng Guangcun , Sun Xueqing , Wang Jinglong , Xiao Gang , Wang Xiumin , Fan Xuemei , Zu Lidong , Hao Mingang , Qu Qing , Mao Yan , Xue Yunjing , Wang Jianhua
Published: April 2023

PDF file - 111K
Supplementary Figure 1 from Activation of the NOTCH Pathway in Head and Neck Cancer
Authors: Sun Wenyue , Gaykalova Daria A. , Ochs Michael F. , Mambo Elizabeth , Arnaoutakis Demetri , Liu Yan , Loyo Myriam , Agrawal Nishant , Howard Jason , Li Ryan , Ahn Sun , Fertig Elana , Sidransky David , Houghton Jeffery , Buddavarapu Kalyan , Sanford Tiffany , Choudhary Ashish , Darden Will , Adai Alex , Latham Gary , Bishop Justin , Sharma Rajni , Westra William H. , Hennessey Patrick , Chung Christine H. , Califano Joseph A.
Published: April 2023

PDF file - 73K, Significant overexpression of JAG1 (A) and PSEN1 (B) in the tumors with increased copy number gains in comparison to that in the normal tissues in the cohort of 44 HNSCC tumors and 25 normal mucosa. N, normal mucosa; T, HNSCC tumors; -, without JAG1(A) or PSEN1 (B) copy number gain; +, with JAG1 (A) or PSEN1 (B) copy number gain. Boxes represent the interquartile range (25th-75th percentile) and horizontal lines inside the boxes indicate median. Whiskers indicate the minimum and maximum values. P value was calculated by using t test.
Supplementary Figure 2 from HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression through Misregulation of LCN2
Authors: Cheng Guangcun , Sun Xueqing , Wang Jinglong , Xiao Gang , Wang Xiumin , Fan Xuemei , Zu Lidong , Hao Mingang , Qu Qing , Mao Yan , Xue Yunjing , Wang Jianhua
Published: April 2023

PDF file - 131K, LCN2 does not affect ERK and NF-kB pathways.
Video S2 from The NADH Oxidase ENOX1, a Critical Mediator of Endothelial Cell Radiosensitization, Is Crucial for Vascular Development
Authors: Venkateswaran Amudhan , Sekhar Konjeti R. , Levic Daniel S. , Melville David B. , Clark Travis A. , Rybski Witold M. , Walsh Alexandra J. , Skala Melissa C. , Crooks Peter A. , Knapik Ela W. , Freeman Michael L.
Published: April 2023

MOV file 5444K, circulation in Enox1 morphant
Supplementary Figure 3 from Acquired Expression of NFATc1 Downregulates E-Cadherin and Promotes Cancer Cell Invasion
Authors: Oikawa Tsukasa , Nakamura Atsuko , Onishi Nobuyuki , Yamada Taketo , Matsuo Koichi , Saya Hideyuki
Published: April 2023

PDF file, 821K, NFATc1 directly activates SNAI1 transcription.
Dataset S2 from The NADH Oxidase ENOX1, a Critical Mediator of Endothelial Cell Radiosensitization, Is Crucial for Vascular Development
Authors: Venkateswaran Amudhan , Sekhar Konjeti R. , Levic Daniel S. , Melville David B. , Clark Travis A. , Rybski Witold M. , Walsh Alexandra J. , Skala Melissa C. , Crooks Peter A. , Knapik Ela W. , Freeman Michael L.
Published: April 2023

XLSX file 47K, Down-regulated genes assigned to GO:0008152 metabolic processing
Supplementary Figure Legends from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
Authors: Lam Adeline R. , Le Bert Nina , Ho Samantha S.W. , Shen Yu J. , Tang Melissa L.F. , Xiong Gordon M. , Croxford J. Ludovic , Koo Christine X. , Ishii Ken J. , Akira Shizuo , Raulet David H. , Gasser Stephan
Published: April 2023

PDF file - 124K
Supplementary Figure and Table Legends from UTX and MLL4 Coordinately Regulate Transcriptional Programs for Cell Proliferation and Invasiveness in Breast Cancer Cells
Authors: Kim Jae-Hwan , Sharma Amrish , Dhar Shilpa S. , Lee Sung-Hun , Gu Bingnan , Chan Chia-Hsin , Lin Hui-Kuan , Lee Min Gyu
Published: April 2023

PDF file - 102KB
Supplementary Figure 7 from CRR9/CLPTM1L Regulates Cell Survival Signaling and Is Required for Ras Transformation and Lung Tumorigenesis
Authors: James Michael A. , Vikis Haris G. , Tate Everett , Rymaszewski Amy L. , You Ming
Published: April 2023

PDF file - 134K, Telomere Length Analysis by 5p Genotype.
Supplementary Figure 4 from CRR9/CLPTM1L Regulates Cell Survival Signaling and Is Required for Ras Transformation and Lung Tumorigenesis
Authors: James Michael A. , Vikis Haris G. , Tate Everett , Rymaszewski Amy L. , You Ming
Published: April 2023

PDF file - 134K, CLPTM1L Regulates Bcl-xL Accumulation and Protects Mouse Lung Tumor Cells from Genotoxic Apoptosis.
Figure S2 from Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
Authors: Adinolfi Elena , Capece Marina , Franceschini Alessia , Falzoni Simonetta , Giuliani Anna L. , Rotondo Alessandra , Sarti Alba C. , Bonora Massimo , Syberg Susanne , Corigliano Domenica , Pinton Paolo , Jorgensen Niklas R. , Abelli Luigi , Emionite Laura , Raffaghello Lizzia , Pistoia Vito , Di Virgilio Francesco
Published: April 2023

Figure S2. Core necrosis in B16 melanomas. Representative images of central necrosis of B16 melanoma masses in P2X7R-KO (A and B) or wt (C and D) mice. Specimens were fixed and stained with haematoxylin-eosin as described in Materials and Methods.
Supplementary Figure 9 from Maximizing the Efficacy of MAPK-Targeted Treatment in PTENLOF/BRAFMUT Melanoma through PI3K and IGF1R Inhibition
Authors: Herkert Barbara , Kauffmann Audrey , Mollé Sandra , Schnell Christian , Ferrat Thomas , Voshol Hans , Juengert Janina , Erasimus Hélène , Marszalek Grégory , Kazic-Legueux Malika , Billy Eric , Ruddy David , Stump Mark , Guthy Daniel , Ristov Mitko , Calkins Keith , Maira Sauveur-Michel , Sellers William R. , Hofmann Francesco , Hall Michael N. , Brachmann Saskia M.
Published: April 2023

Cartoon illustrating the requirement of concomitant inhibition of PI3Kβ together with PI3Kα or IGF1R and MAPK signaling to achieve complete long-term pathway inhibition in PTENLOF/BRAFMUT melanoma.
Supplementary Figure 8 from Maximizing the Efficacy of MAPK-Targeted Treatment in PTENLOF/BRAFMUT Melanoma through PI3K and IGF1R Inhibition
Authors: Herkert Barbara , Kauffmann Audrey , Mollé Sandra , Schnell Christian , Ferrat Thomas , Voshol Hans , Juengert Janina , Erasimus Hélène , Marszalek Grégory , Kazic-Legueux Malika , Billy Eric , Ruddy David , Stump Mark , Guthy Daniel , Ristov Mitko , Calkins Keith , Maira Sauveur-Michel , Sellers William R. , Hofmann Francesco , Hall Michael N. , Brachmann Saskia M.
Published: April 2023

PI3K pathway inhibition using PI3Kβi/PI3Kαi or PI3Kβi/IGF1Ri enhances the anti-proliferative effect of the BRAF/MEK inhibition regimen in PTENLOF/BRAFMUT cell lines and shifts the response towards cell death A+B) Validation of BRAFi/MEKi activity in RVH-421 (A) and WM-266-4 (B) in the absence or presence of PI3Kβi/PI3Kαi or PI3Kβi/IGF1Ri using proliferation (upper panels; growth matrix highlighting percentages of proliferation inhibition relative to DMSO) or cell death assays (lower panels; fraction of PI-positive, dead cells). PI3Kβi=rac-KIN-193, PI3Kαi=BYL719, IGF1Ri=AEW541, BRAFi=LGX818, MEKi=MEK162
Supplementary Figure 6 from Maximizing the Efficacy of MAPK-Targeted Treatment in PTENLOF/BRAFMUT Melanoma through PI3K and IGF1R Inhibition
Authors: Herkert Barbara , Kauffmann Audrey , Mollé Sandra , Schnell Christian , Ferrat Thomas , Voshol Hans , Juengert Janina , Erasimus Hélène , Marszalek Grégory , Kazic-Legueux Malika , Billy Eric , Ruddy David , Stump Mark , Guthy Daniel , Ristov Mitko , Calkins Keith , Maira Sauveur-Michel , Sellers William R. , Hofmann Francesco , Hall Michael N. , Brachmann Saskia M.
Published: April 2023

Concomitant inhibition of PI3Kβ, IGF1R and MAPK signaling are leading to full long-term pathway blockade. A) +B) Effects of treatment with the indicated inhibitors as single-agents or in combination on WM-266-4 (A) or RVH-421 (B) were evaluated by immunoblotting using phospho-specific or total target protein antibodies. PI3Kβi=rac-KIN-193, PI3Kαi=BYL719, IGF1Ri (A)=AEW541, IGF1Ri (B)=Figitumumab-like antibody, MEKi=MEK162
Supplementary Table 2 from Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas
Authors: Tang Xiaohu , Wu Jianli , Ding Chien-Kuang , Lu Min , Keenan Melissa M. , Lin Chao-Chieh , Lin Chih-An , Wang Charles C. , George Daniel , Hsu David S. , Chi Jen-Tsan
Published: April 2023

Supplementary Table 2. Metabolomics of 786-O VHL-deficient and -restored cells upon cystine deprivation
Supplementary Figure 6 from miR-892b Silencing Activates NF-κB and Promotes Aggressiveness in Breast Cancer
Authors: Jiang Lili , Yu Liang , Zhang Xin , Lei Fangyong , Wang Lan , Liu Xiangxia , Wu Shu , Zhu Jinrong , Wu Geyan , Cao Lixue , Liu Aibin , Song Libing , Li Jun
Published: April 2023

Supplementary Figure 6. Downregulation of miR-892b is attributed to hypermethylation of its promoter.
Figure S11 from miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer
Authors: Orso Francesca , Quirico Lorena , Virga Federico , Penna Elisa , Dettori Daniela , Cimino Daniela , Coppo Roberto , Grassi Elena , Elia Angela Rita , Brusa Davide , Deaglio Silvia , Brizzi Maria Felice , Stadler Michael B. , Provero Paolo , Caselle Michele , Taverna Daniela
Published: April 2023

miR-148b target genes analysis
Supplementary Figure Legend from Ovarian Cancers Harboring Inactivating Mutations in CDK12 Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications
Authors: Popova Tatiana , Manié Elodie , Boeva Valentina , Battistella Aude , Goundiam Oumou , Smith Nicholas K. , Mueller Christopher R. , Raynal Virginie , Mariani Odette , Sastre-Garau Xavier , Stern Marc-Henri
Published: April 2023

Legends of the 22 Supplementary Figures
Supplementary Figure S2 from Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
Authors: Beziaud Laurent , Mansi Laura , Ravel Patrice , Marie-Joseph Elodie Lauret , Laheurte Caroline , Rangan Laurie , Bonnefoy Francis , Pallandre Jean-René , Boullerot Laura , Gamonet Clémentine , Vrecko Sindy , Queiroz Lise , Maurina Tristan , Mouillet Guillaume , Hon Thierry Nguyen Tan , Curtit Elsa , Royer Bernard , Gaugler Béatrice , Bayry Jagadeesh , Tartour Eric , Thiery-Vuillemin Antoine , Pivot Xavier , Borg Christophe , Godet Yann , Adotévi Olivier
Published: April 2023

This file contains the lymphocytes count in patients: Supplementary figure 2
Supplementary Figure S4 from Upregulation of Cytosolic Phosphoenolpyruvate Carboxykinase Is a Critical Metabolic Event in Melanoma Cells That Repopulate Tumors
Authors: Li Yong , Luo Shunqun , Ma Ruihua , Liu Jing , Xu Pingwei , Zhang Huafeng , Tang Ke , Ma Jingwei , Zhang Yi , Liang Xiaoyu , Sun Yanling , Ji Tiantian , Wang Ning , Huang Bo
Published: April 2023

Supplementary Figure S4. PCK1 knockdown did not affect the expression of metabolic enzymes in B16 TRCs.
Supplementary Figures and Figure Legends from NRBP2 Overexpression Increases the Chemosensitivity of Hepatocellular Carcinoma Cells via Akt Signaling
Authors: Zhang Lixing , Ge Chao , Zhao Fangyu , Zhang Yang , Wang Xin , Yao Ming , Li Jinjun
Published: April 2023

Supplementary Figures and Figure Legends that contain the information of NRBP2 expression in HCC and NSCLC cell lines, xenograft tumor picture, Annexin V/7-AAD assay results, the HCC cell stemness after ANXA2 knockdown and the effects of perifosine on HCC cell stemness.
Supplementary Table S1 from Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3′-Deoxy-3′-[18F]Fluorothymidine in Preclinical Models of Lung Cancer
Authors: Schelhaas Sonja , Held Annelena , Wachsmuth Lydia , Hermann Sven , Honess Davina J. , Heinzmann Kathrin , Smith Donna-Michelle , Griffiths John R. , Faber Cornelius , Jacobs Andreas H.
Published: April 2023

Mean and standard deviation, as well as number of samples analyzed (in brackets), of other PET image quantification approaches.
Supplementary Figure 5 from AIMP2 Controls Intestinal Stem Cell Compartments and Tumorigenesis by Modulating Wnt/β-Catenin Signaling
Authors: Yum Min Kyu , Kang Jong-Seol , Lee Al-Eum , Jo Young-Woo , Seo Ji-Yun , Kim Hyun-A , Kim Yoon-Young , Seong Jinwoo , Lee Eun Byul , Kim Ji-Hoon , Han Jung Min , Kim Sunghoon , Kong Young-Yun
Published: April 2023

Aimp2 gene dosage negatively correlates with organoid growth
Table S4 from Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas
Authors: Buffet Alexandre , Morin Aurélie , Castro-Vega Luis-Jaime , Habarou Florence , Lussey-Lepoutre Charlotte , Letouzé Eric , Lefebvre Hervé , Guilhem Isabelle , Haissaguerre Magalie , Raingeard Isabelle , Padilla-Girola Mathilde , Tran Thi , Tchara Lucien , Bertherat Jérôme , Amar Laurence , Ottolenghi Chris , Burnichon Nelly , Gimenez-Roqueplo Anne-Paule , Favier Judith
Published: April 2023

Supplementary Table S4
Supplementary Table S4 from Integrative Genome-Wide Analysis of Long Noncoding RNAs in Diverse Immune Cell Types of Melanoma Patients
Authors: Wang Lei , Felts Sara J. , Van Keulen Virginia P. , Scheid Adam D. , Block Matthew S. , Markovic Svetomir N. , Pease Larry R. , Zhang Yuji
Published: April 2023

The information of the cis-regulatory lncRNAs.
Suppl Figure 5 from BET Inhibition Overcomes Receptor Tyrosine Kinase–Mediated Cetuximab Resistance in HNSCC
Authors: Leonard Brandon , Brand Toni M. , O'Keefe Rachel A. , Lee Eliot D. , Zeng Yan , Kemmer Jacquelyn D. , Li Hua , Grandis Jennifer R. , Bhola Neil E.
Published: April 2023

Lung cancer model of acquired cetuximab resistance display increased RTK expression and sensitivity to BET inhibition
Supplemental Table 2 from PADI2-Mediated Citrullination Promotes Prostate Cancer Progression
Authors: Wang Lin , Song Guanhua , Zhang Xiang , Feng Tingting , Pan Jihong , Chen Weiwen , Yang Muyi , Bai Xinnuo , Pang Yu , Yu Jindan , Han Jinxiang , Han Bo
Published: April 2023

siRNA sequence used in this study
Supplementary Figure S7A-B from Preclinical Evaluation of the Hsp70 Peptide Tracer TPP-PEG24-DFO[89Zr] for Tumor-Specific PET/CT Imaging
Authors: Stangl Stefan , Tei Lorenzo , De Rose Francesco , Reder Sybille , Martinelli Jonathan , Sievert Wolfgang , Shevtsov Maxim , Öllinger Rupert , Rad Roland , Schwaiger Markus , D'Alessandria Calogero , Multhoff Gabriele
Published: April 2023

In vivo stability of TPP-PEG24-DFO[89Zr] in blood, kidney, liver, 4T1 and CT26 tumors
Supplementary Figure S6A-B from Preclinical Evaluation of the Hsp70 Peptide Tracer TPP-PEG24-DFO[89Zr] for Tumor-Specific PET/CT Imaging
Authors: Stangl Stefan , Tei Lorenzo , De Rose Francesco , Reder Sybille , Martinelli Jonathan , Sievert Wolfgang , Shevtsov Maxim , Öllinger Rupert , Rad Roland , Schwaiger Markus , D'Alessandria Calogero , Multhoff Gabriele
Published: April 2023

Epifluorescence measurements of TPP[Cy5.5] in 4T1 wild type and Hsp70 knock-out tumors
Supplementary Tables S1,S2,S3,S4,S9 from Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations
Authors: Sowalsky Adam G. , Ye Huihui , Bhasin Manoj , Van Allen Eliezer M. , Loda Massimo , Lis Rosina T. , Montaser-Kouhsari Laleh , Calagua Carla , Ma Fen , Russo Joshua W. , Schaefer Rachel J. , Voznesensky Olga S. , Zhang Zhenwei , Bubley Glenn J. , Montgomery Bruce , Mostaghel Elahe A. , Nelson Peter S. , Taplin Mary-Ellen , Balk Steven P.
Published: April 2023

Supplementary Table S1. Clinicopathologic characteristics of microdissected cases; Supplementary Table S2. Genes up-regulated by 2-fold or more in the treated vs. untreated cases; Supplementary Table S3. Fold change in expression of AR coactivators in treated versus untreated cases; Supplementary Table S4. Genes down-regulated by 2-fold or more in the treated versus untreated cases; Supplementary Table S9. Number of genomic alterations in each focus.
Supplemental Information from Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations
Authors: Sowalsky Adam G. , Ye Huihui , Bhasin Manoj , Van Allen Eliezer M. , Loda Massimo , Lis Rosina T. , Montaser-Kouhsari Laleh , Calagua Carla , Ma Fen , Russo Joshua W. , Schaefer Rachel J. , Voznesensky Olga S. , Zhang Zhenwei , Bubley Glenn J. , Montgomery Bruce , Mostaghel Elahe A. , Nelson Peter S. , Taplin Mary-Ellen , Balk Steven P.
Published: April 2023

Supplemental Methods, Figure Legends, Table Legends, References
Supplementary methods from Optimized Dosing Schedule Based on Circadian Dynamics of Mouse Breast Cancer Stem Cells Improves the Antitumor Effects of Aldehyde Dehydrogenase Inhibitor
Authors: Matsunaga Naoya , Ogino Takashi , Hara Yukinori , Tanaka Takahiro , Koyanagi Satoru , Ohdo Shigehiro
Published: April 2023

Supplementary methods
Supplementary Table S3 and S4 from p63-Dependent Dickkopf3 Expression Promotes Esophageal Cancer Cell Proliferation via CKAP4
Authors: Kajiwara Chihiro , Fumoto Katsumi , Kimura Hirokazu , Nojima Satoshi , Asano Keita , Odagiri Kazuki , Yamasaki Makoto , Hikita Hayato , Takehara Tetsuo , Doki Yuichiro , Morii Eiichi , Kikuchi Akira
Published: April 2023

Univariate (Supplementary Table S3) and multivariate (Supplementary Table S4) analysis of overall survival.
Supplementary Table 1 from The EGFR T790M Mutation Is Acquired through AICDA-Mediated Deamination of 5-Methylcytosine following TKI Treatment in Lung Cancer
Authors: El Kadi Najwa , Wang Luo , Davis April , Korkaya Hasan , Cooke Alexander , Vadnala Varun , Brown Noah A. , Betz Bryan L. , Cascalho Marilia , Kalemkerian Gregory P. , Hassan Khaled A.
Published: April 2023

Patients' clinical data.
Supplementary Tables from Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma
Authors: Sato Takashi , Yoo Seungyeul , Kong Ranran , Sinha Abhilasha , Chandramani-Shivalingappa Prashanth , Patel Ayushi , Fridrikh Maya , Nagano Osamu , Masuko Takashi , Beasley Mary Beth , Powell Charles A. , Zhu Jun , Watanabe Hideo
Published: April 2023

ST1: Original sources for the cell lines used in this study. ST2: sgRNA sequences for CRISPR-Cas9 system and primers for quantitative reverse transcription PCR. ST3: Characteristics of human primary LUSC tumor specimens for immunohistochemistry. ST4: Gene loci for super-enhancers near transcriptional regulators shared by all the LUSC cell lines in 'classical' subgroup. ST5: Gene loci for super-enhancers with highest signals near transcriptional regulators in LK2 and NCI-H520 cells. ST6: Associations between gene signatures from DNp63-overexpressed LK2 model and those from human TCGA-LUSC dataset based on POU3F2/ TP63 expression.
Figure S1-S3 from Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma
Authors: Jung Jinkyu , Zhang Ying , Celiku Orieta , Zhang Wei , Song Hua , Williams Brian J. , Giles Amber J. , Rich Jeremy N. , Abounader Roger , Gilbert Mark R. , Park Deric M.
Published: April 2023

NIX expression is enriched in glioblastoma patient tissues.
Supplementary Tables S1-S5, S7-S8, S10 from Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3
Authors: Zheng Zi-Qi , Li Zhi-Xuan , Zhou Guan-Qun , Lin Li , Zhang Lu-Lu , Lv Jia-Wei , Huang Xiao-Dan , Liu Rui-Qi , Chen FoPing , He Xiao-Jun , Kou Jia , Zhang Jian , Wen Xin , Li Ying-Qin , Ma Jun , Liu Na , Sun Ying
Published: April 2023

Supplementary Table S1. qPCR primers used in this study Supplementary Table S2. The FAM225A expression level and grouping of samples based on GEO dataset (GSE12452) Supplementary Table S3. Primers used for shRNA plasmid construction Supplementary Table S4. Sequence of miRNA mimic or inhibitor used in this study Supplementary Table S5. Probe sequence of FAM225A in situ hybridization (ISH) Supplementary Table S7. Clinical characteristics of nasopharyngeal carcinoma patients according to the high and low expression of FAM225A. Supplementary Table S8. Univariate and multivariable Cox regression analysis of FAM225A expression level and survival. Supplementary Table S10. Inguinal lymph node metastasis in vivo.
Figure S10 from Cancer Exacerbates Chemotherapy-Induced Sensory Neuropathy
Authors: Housley Stephen N. , Nardelli Paul , Carrasco Dario I. , Rotterman Travis M. , Pfahl Emily , Matyunina Lilya V. , McDonald John F. , Cope Timothy C.
Published: April 2023

Model of molecular determinants of neuronal signaling of sensory neurons
Supplementary Figures S2-S4 from Transcriptomics Associates Molecular Features with 18F-Fluorocholine PET/CT Imaging Phenotype and Its Potential Relationship to Survival in Hepatocellular Carcinoma
Authors: Kwee Sandi A. , Tiirikainen Maarit , Sato Miles M. , Acoba Jared D. , Wei Runmin , Jia Wei , Le Marchand Loic , Wong Linda L.
Published: April 2023

Heat Maps
Supplementary Data from FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy
Authors: Manfrini Nicola , Mancino Marilena , Miluzio Annarita , Oliveto Stefania , Balestra Matteo , Calamita Piera , Alfieri Roberta , Rossi Riccardo L. , Sassoè-Pognetto Marco , Salio Chiara , Cuomo Alessandro , Bonaldi Tiziana , Manfredi Marcello , Marengo Emilio , Ranzato Elia , Martinotti Simona , Cittaro Davide , Tonon Giovanni , Biffo Stefano
Published: April 2023

Supplementary Figures
Figure S4 from The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 Tumors
Authors: Spiegelberg Diana , Mortensen Anja C. , Lundsten Sara , Brown Christopher J. , Lane David P. , Nestor Marika
Published: April 2023

Supplemental Figure 4: Effects of PM2 treatment in UM-SCC-74B (wt p53) and BON (mutant p53) xenografts. A) Ex vivo immunohistochemistry images of p53 expression in control or PM2-treated UM-SCC-74B xenografts taken at the last treatment day. Staining intensity was assessed as + for control xenografts, and ++ for PM2-treated xenografts. B) Ex vivo immunohistochemistry images of p53 expression in control or PM2-treated BON xenografts taken at the last treatment day. Staining intensity was assessed as +++ for both groups. C) UM-SCC-74B tumor growth followed for one week during treatment. Animals were either mock treated or treated with fractionated PM2 therapy. Data is normalized to the first measurement after treatment start (n {greater than or equal to} 4 per group, error bars = 95 % CI). D) BON tumor growth followed for one week during treatment. Animals were either mock treated or treated with fractionated PM2 therapy. Data is normalized to the first measurement after treatment start (n = 5 per group, error bars = 95 % CI).
Table S6 from A Deep Learning Framework Identifies Pathogenic Noncoding Somatic Mutations from Personal Prostate Cancer Genomes
Authors: Wang Cheng , Li Jingjing
Published: April 2023

Enrichment of genes targeted by transcription factors (TF). The TF received the highest enrichment was the androgen receptor (AR).
Figure S6 from Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis
Authors: Shabaneh Tamer B. , Molodtsov Aleksey K. , Steinberg Shannon M. , Zhang Peisheng , Torres Gretel M. , Mohamed Gadisti A. , Boni Andrea , Curiel Tyler J. , Angeles Christina V. , Turk Mary Jo
Published: April 2023

Histologic and molecular analysis of nevus-induced skin
Supplementary Figures S1-S2 from Psychiatric Disorders Are Associated with Increased Risk of Sepsis Following a Cancer Diagnosis
Authors: Liu Qianwei , Song Huan , Andersson Therese M.-L. , Magnusson Patrik K.E. , Zhu Jianwei , Smedby Karin E. , Fang Fang
Published: April 2023

Figure S1. Flow chart. Figure S2 Hazard ratios and 95% confidence intervals of sepsis among cancer patients with psychiatric disorders (defined through clinical diagnosis of psychiatric disorder more than one year before cancer diagnosis) compared to cancer patients without psychiatric disorders, a cohort study in Sweden, 2006-2014.
Figure S1 from Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis
Authors: Shabaneh Tamer B. , Molodtsov Aleksey K. , Steinberg Shannon M. , Zhang Peisheng , Torres Gretel M. , Mohamed Gadisti A. , Boni Andrea , Curiel Tyler J. , Angeles Christina V. , Turk Mary Jo
Published: April 2023

Tregs expand in tumor draining lymph nodes
Dataset S1 from Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death
Authors: Cottone Lucia , Cribbs Adam P. , Khandelwal Garima , Wells Graham , Ligammari Lorena , Philpott Martin , Tumber Anthony , Lombard Patrick , Hookway Edward S. , Szommer Tamas , Johansson Catrine , Brennan Paul E. , Pillay Nischalan , Jenner Richard G. , Oppermann Udo , Flanagan Adrienne M.
Published: April 2023

Compounds_Library_screen data
Supplementary Figure 2 from Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling
Authors: Wullweber Adrian , Strick Reiner , Lange Fabienne , Sikic Danijel , Taubert Helge , Wach Sven , Wullich Bernd , Bertz Simone , Weyerer Veronika , Stoehr Robert , Breyer Johannes , Burger Maximilian , Hartmann Arndt , Strissel Pamela L. , Eckstein Markus
Published: April 2023

(A) Unsupervised hierarchical clustering of tumor subtyping protein markers determined by semiquantitative immunohistochemistry (CK5, CK14, CD44, CK20, GATA3, FOXA1, UPKII) reveals a basal and luminal cluster. (B) HER2/neu protein expression (left panel) and ERBB2/CEN17-ratio in the WBHM samples. HER2/neu protein expression and its genetically detected ERBB2-gene locus amplification co-occur in CIS, pT1 carcinomas and MIBCs. (C) Distribution of "Normal-like", "Transforming-like" and "Invasive-like" cluster assignments in the WBHM scheme illustrates "Invasive-like" lesions surrounded by "Transforming-like" lesions. CIS = Carcinoma in situ; DYS = Dysplasia; UPUMP/HYP = urothelial proliferation of unknown malignant potential/ hyperplasia (abbreviated as "HYP" in graphs); IRS = Immunoreactive score; MIBC = Muscle-invasive bladder cancer; pT1 = Stroma invasive bladder cancer; U = Tumor associated urothelium.
Supplementary Data 3 from Changes in Keratin Expression during Metastatic Progression of Breast Cancer: Impact on the Detection of Circulating Tumor Cells
Authors: Joosse Simon A. , Hannemann Juliane , Spötter Julia , Bauche Andreas , Andreas Antje , Müller Volkmar , Pantel Klaus
Published: April 2023

PDF file - 22K, Average keratin gene expression levels and standard deviations (s) measured by 20 microarray probes. Data was collected from 52 breast cancer cell lines from a published study by Neve et al. 24 and sorted per subtype. P-values were calculated by 2-sided t-test and corrected for multiple testing, (*) significant p-values (p<0.0005, Bonferonni).
Suppl. Figure 8 from Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma
Authors: Dettling Steffen , Stamova Slava , Warta Rolf , Schnölzer Martina , Rapp Carmen , Rathinasamy Anchana , Reuss David , Pocha Kolja , Roesch Saskia , Jungk Christine , Warnken Uwe , Eckstein Volker , Grabe Niels , Schramm Christoph , Weigand Markus A. , von Deimling Andreas , Unterberg Andreas , Beckhove Philipp , Herold-Mende Christel
Published: April 2023

Usage of RNA Seq TCGA data of IDHmut LGG tumors to compare mRNA expression levels with T-cell infiltration. Significant increased expression of NME2 in the TCGA IDHmut LGG dataset was shown to be positively correlated with the expression of CD3E (encoding CD3-Îµ as part of the CD3 T-cell receptor complex) (r = 0.2352). Stronger correlation in the histology of astrocytomas (r = 0.3693**) than in oligodendrogliomas (r = 0.1919**). (*, p < 0.05; **, p < 0.01; ***, p < 0.001)
Table S1 from 5-Fluorouracil Enhances Protoporphyrin IX Accumulation and Lesion Clearance during Photodynamic Therapy of Actinic Keratoses: A Mechanism-Based Clinical Trial
Authors: Maytin Edward V. , Anand Sanjay , Riha Margo , Lohser Sara , Tellez Alejandra , Ishak Rim , Karpinski Lauren , Sot Janine , Hu Bo , Denisyuk Anton , Davis Scott C. , Kyei Angela , Vidimos Allison
Published: April 2023

Demographics of enrolled patients
Supplemental Figure 3 from A Novel Breast Cancer Index for Prediction of Distant Recurrence in HR+ Early-Stage Breast Cancer with One to Three Positive Nodes
Authors: Zhang Yi , Schroeder Brock E. , Jerevall Piiha-Lotta , Ly Amy , Nolan Hannah , Schnabel Catherine A. , Sgroi Dennis C.
Published: April 2023

Supplemental Figure 3 shows the discriminative performance of BCIN+ by ROC analysis for 15-year distant recurrence in patients with 1-3 positive nodes.
Supplementary Table 1-4, Supplementary Figures 1-3 from An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia
Authors: Shouval Roni , Ruggeri Annalisa , Labopin Myriam , Mohty Mohamad , Sanz Guillermo , Michel Gerard , Kuball Jürgen , Chevallier Patrice , Al-Seraihy Amal , Milpied Noel-Jean , de Heredia Cristina Diaz , Arcese William , Blaise Didier , Rocha Vanderson , Fein Joshua , Unger Ron , Baron Frederic , Bader Peter , Gluckman Eliane , Nagler Arnon
Published: April 2023

Table S1: Data set country allocation; Table S2. A Cox regression model for 2 year overall survival considering top predictors- no interactions considered; Table S3. A Cox regression model for 2 year overall survival considering top predictors with interactions considered; Table S4: Population characteristics of a randomly selected imputed data set; Table S5. Risk for 2-years OS and 2-years LFS categorized by the UCBT score; Table S6. Probabilities for OS, LFS, NRM, and RI stratified by the UCBT score over 20 imputed datasets; Table S7: The population characteristics across the UCBT risk score categories over the validation set; Figure S1. Estimation of predictor importance using the Random Survival Forest minimal depth; Figure S2: Interaction analysis using conditional plots; Figure S3: A calibration plot of the risk scores between predicted and observed events (death) at two years, according to pentiles.
Supplemental Figure 3 from Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer
Authors: Doostan Iman , Karakas Cansu , Kohansal Mehrnoosh , Low Kwang-Hui , Ellis Matthew J. , Olson John A. , Suman Vera J. , Hunt Kelly K. , Moulder Stacy L. , Keyomarsi Khandan
Published: April 2023

Low molecular weight cyclin E (LMW-E), but not full-length cyclin E, bypasses aromatase inhibitor-mediated inhibition of proliferation.
Supplementary Figures S1 and S2: Association of MRD with survival outcomes in myeloma patients from The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications
Authors: Anderson Kenneth C. , Auclair Daniel , Kelloff Gary J. , Sigman Caroline C. , Avet-Loiseau Hervé , Farrell Ann T. , Gormley Nicole J. , Kumar Shaji K. , Landgren Ola , Munshi Nikhil C. , Cavo Michele , Davies Faith E. , Di Bacco Alessandra , Dickey Jennifer S. , Gutman Steven I. , Higley Howard R. , Hussein Mohamad A. , Jessup J. Milburn , Kirsch Ilan R. , Little Richard F. , Loberg Robert D. , Lohr Jens G. , Mukundan Lata , Omel James L. , Pugh Trevor J. , Reaman Gregory H. , Robbins Michael D. , Sasser A. Kate , Valente Nancy , Zamagni Elena
Published: April 2023

1) Munshi Figures, 2) MRD Negativity Associated With Longer Progression-free Survival And Overall Survival In Newly Diagnosed Multiple Myeloma Patients
Supplementary File 6 from A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers
Authors: Paik Paul K. , Shen Ronglai , Berger Michael F. , Ferry David , Soria Jean-Charles , Mathewson Alastair , Rooney Claire , Smith Neil R. , Cullberg Marie , Kilgour Elaine , Landers Donal , Frewer Paul , Brooks Nigel , André Fabrice
Published: April 2023

AZD4547 dose intensity
Supplementary Data from The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma
Authors: Kim Sun-Hee , Roszik Jason , Cho Sung-Nam , Ogata Dai , Milton Denái R. , Peng Weiyi , Menter David G. , Ekmekcioglu Suhendan , Grimm Elizabeth A.
Published: April 2023

Supplementary methods and materials and figure legends
Supplementary Data from Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer
Authors: Greally Megan , Chou Joanne F. , Chatila Walid K. , Margolis Matthew , Capanu Marinela , Hechtman Jaclyn F. , Tuvy Yaelle , Kundra Ritika , Daian Foysal , Ladanyi Marc , Kelsen David P. , Ilson David H. , Berger Michael F. , Tang Laura H. , Solit David B. , Diaz Luis A. , Schultz Nikolaus , Janjigian Yelena Y. , Ku Geoffrey Y.
Published: April 2023

PFS analysis by gene alteration occurring in 10% or more of MSS patients
Supplementary Table S1 from Use of Ex Vivo Patient-Derived Tumor Organotypic Spheroids to Identify Combination Therapies for HER2 Mutant Non–Small Cell Lung Cancer
Authors: Ivanova Elena , Kuraguchi Mari , Xu Man , Portell Andrew J. , Taus Luke , Diala Irmina , Lalani Alshad S. , Choi Jihyun , Chambers Emily S. , Li Shuai , Liu Shengwu , Chen Ting , Barbie Thanh U. , Oxnard Geoffrey R. , Haworth Jacob J. , Wong Kwok-Kin , Dahlberg Suzanne E. , Aref Amir A. , Barbie David A. , Bahcall Magda , Paweletz Cloud P. , Jänne Pasi A.
Published: April 2023

Supplementary Table S1
Appendix S1 from Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort
Authors: Dihge Looket , Vallon-Christersson Johan , Hegardt Cecilia , Saal Lao H. , Häkkinen Jari , Larsson Christer , Ehinger Anna , Loman Niklas , Malmberg Martin , Bendahl Pär-Ola , Borg Åke , Staaf Johan , Rydén Lisa
Published: April 2023

Supplementary information on material and methods
Supplementary Materials & Methods from The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy
Authors: Schaer David A. , Geeganage Sandaruwan , Amaladas Nelusha , Lu Zhao Hai , Rasmussen Erik R. , Sonyi Andreas , Chin Darin , Capen Andrew , Li Yanxia , Meyer Catalina M. , Jones Bonita D. , Huang Xiaodong , Luo Shuang , Carpenito Carmine , Roth Kenneth D. , Nikolayev Alexander , Tan Bo , Brahmachary Manisha , Chodavarapu Krishna , Dorsey Frank C. , Manro Jason R. , Doman Thompson N. , Donoho Gregory P. , Surguladze David , Hall Gerald E. , Kalos Michael , Novosiadly Ruslan D.
Published: April 2023

Supplementary Materials & Methods
Figure S2 from NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric Cancer
Authors: Gambardella Valentina , Gimeno-Valiente Francisco , Tarazona Noelia , Ciarpaglini Carolina Martinez , Roda Desamparados , Fleitas Tania , Tolosa Pablo , Cejalvo Juan Miguel , Huerta Marisol , Roselló Susana , Castillo Josefa , Cervantes Andrés
Published: April 2023

NRF2 expression analysed by Western Blot after subcellular fractionation.
Supplementary Tables from Treatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation Diversity
Authors: Dagogo-Jack Ibiayi , Rooney Marguerite , Lin Jessica J. , Nagy Rebecca J. , Yeap Beow Y. , Hubbeling Harper , Chin Emily , Ackil Jennifer , Farago Anna F. , Hata Aaron N. , Lennerz Jochen K. , Gainor Justin F. , Lanman Richard B. , Shaw Alice T.
Published: April 2023

Supplementary Tables
Suppl. Fig. 8 from Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment
Authors: Luo Ren , Firat Elke , Gaedicke Simone , Guffart Elena , Watanabe Tsubasa , Niedermann Gabriele
Published: April 2023

Graphical summary.
Supplementary Figure 9 from Oxygen-enhanced MRI Is Feasible, Repeatable, and Detects Radiotherapy-induced Change in Hypoxia in Xenograft Models and in Patients with Non–small Cell Lung Cancer
Authors: Salem Ahmed , Little Ross A. , Latif Ayşe , Featherstone Adam K. , Babur Muhammad , Peset Isabel , Cheung Susan , Watson Yvonne , Tessyman Victoria , Mistry Hitesh , Ashton Garry , Behan Caron , Matthews Julian C. , Asselin Marie-Claude , Bristow Robert G. , Jackson Alan , Parker Geoff J.M. , Faivre-Finn Corinne , Williams Kaye J. , O'Connor James P.B.
Published: April 2023

Supplementary Figure 9
Supplementary Figure 2 from Long-Term Survival Analysis of Adjuvant Chemotherapy with or without Trastuzumab in Patients with T1, Node-Negative HER2-Positive Breast Cancer
Authors: He Xuexin , Ji Jiali , Tian Mei , Esteva Francisco J. , Hortobagyi Gabriel N. , Yeung Sai-Ching Jim
Published: April 2023

Supplementary Figure S2. Tumor size cutoff and standardized Wilcoxon statistic for (A) disease-free survival (DFS), (B) overall survival (OS), (C) breast cancer-specific survival (BCSS), and (D) distant recurrence-free survival (DRFS) in patients with pT1N0M0 HER2-positive breast cancer.
Supplementary Legend from Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs
Authors: Kiseleva Anna A. , Korobeynikov Vladislav A. , Nikonova Anna S. , Zhang Peishan , Makhov Petr , Deneka Alexander Y. , Einarson Margret B. , Serebriiskii Ilya G. , Liu Hanqing , Peterson Jeffrey R. , Golemis Erica A.
Published: April 2023

Supplementary Legend from Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs
Supplementary Table S1 from Investigating PSMA-Targeted Radioligand Therapy Efficacy as a Function of Cellular PSMA Levels and Intratumoral PSMA Heterogeneity
Authors: Current Kyle , Meyer Catherine , Magyar Clara E. , Mona Christine E. , Almajano Joel , Slavik Roger , Stuparu Andreea D. , Cheng Chloe , Dawson David W. , Radu Caius G. , Czernin Johannes , Lueckerath Katharina
Published: April 2023

Relative tumor volumes, 177Lu-/225Ac-PSMA617 uptake and 53BP1 IRS
Appendix 4 from Predicting the 1p/19q Codeletion Status of Presumed Low-Grade Glioma with an Externally Validated Machine Learning Algorithm
Authors: van der Voort Sebastian R. , Incekara Fatih , Wijnenga Maarten M.J. , Kapas Georgios , Gardeniers Mayke , Schouten Joost W. , Starmans Martijn P.A. , Nandoe Tewarie Rishie , Lycklama Geert J. , French Pim J. , Dubbink Hendrikus J. , van den Bent Martin J. , Vincent Arnaud J.P.E. , Niessen Wiro J. , Klein Stefan , Smits Marion
Published: April 2023

Excluded patients from TCIA-1p19qDeletion dataset
Table S2 from Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti–PD-(L)1 Therapies in Non–Small Cell Lung Cancer
Authors: Fang Wenfeng , Ma Yuxiang , Yin Jiani C. , Hong Shaodong , Zhou Huaqiang , Wang Ao , Wang Fufeng , Bao Hua , Wu Xue , Yang Yunpeng , Huang Yan , Zhao Hongyun , Shao Yang W. , Zhang Li
Published: April 2023

Individual gene mutations correlate with immunotherapy response in both Rizvi et al and our data
Supplementary Figure legends from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma
Authors: Chen Robert , Herrera Alex F. , Hou Jessie , Chen Lu , Wu Jun , Guo Yuming , Synold Timothy W. , Ngo Vu N. , Puverel Sandrine , Mei Matthew , Popplewell Leslie , Yi Shuhua , Song Joo Y. , Tao Shu , Wu Xiwei , Chan Wing C. , Forman Stephen J. , Kwak Larry W. , Rosen Steven T. , Newman Edward M.
Published: April 2023

Supplementary Figure legends
Supplementary Data from Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
Authors: de la Iglesia Janis V. , Slebos Robbert J.C. , Martin-Gomez Laura , Wang Xuefeng , Teer Jamie K. , Tan Aik Choon , Gerke Travis A. , Aden-Buie Garrick , van Veen Tessa , Masannat Jude , Chaudhary Ritu , Song Feifei , Fournier Michelle , Siegel Erin M. , Schabath Matthew B. , Wadsworth J. Trad , Caudell Jimmy , Harrison Louis , Wenig Bruce M. , Conejo-Garcia Jose , Hernandez-Prera Juan C. , Chung Christine H.
Published: April 2023

Supplementary Table 2, 5 Supplementary Figure 1-6
Supplementary Figures from Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer
Authors: Rashid Naim U. , Peng Xianlu L. , Jin Chong , Moffitt Richard A. , Volmar Keith E. , Belt Brian A. , Panni Roheena Z. , Nywening Timothy M. , Herrera Silvia G. , Moore Kristin J. , Hennessey Sarah G. , Morrison Ashley B. , Kawalerski Ryan , Nayyar Apoorve , Chang Audrey E. , Schmidt Benjamin , Kim Hong Jin , Linehan David C. , Yeh Jen Jen
Published: April 2023

Supplementary Figures
Supplementary Data from Cancer-associated Fibroblast–promoted LncRNA DNM3OS Confers Radioresistance by Regulating DNA Damage Response in Esophageal Squamous Cell Carcinoma
Authors: Zhang Hongfang , Hua Yuhui , Jiang Zhenzhen , Yue Jing , Shi Ming , Zhen Xiaoli , Zhang Xiaoyan , Yang Ling , Zhou Rongjing , Wu Shixiu
Published: April 2023

Supplementary Figure. S5 DNM3OS inhibited irradiation-induced DNA damage in esophageal cancer cells by FCM analysis.
Figure S2 from Depression-Induced Neuropeptide Y Secretion Promotes Prostate Cancer Growth by Recruiting Myeloid Cells
Authors: Cheng Yan , Tang Xin-Ying , Li Yi-Xuan , Zhao Dan-Dan , Cao Qiu-Hua , Wu Hong-Xi , Yang Hong-Bao , Hao Kun , Yang Yong
Published: April 2023

T cell analysis in Myc-CaP tumors and Hi-myc prostates.
Supplementary Figure 2 from Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG
Authors: Raut Chandrajit P. , Callegaro Dario , Miceli Rosalba , Barretta Francesco , Rutkowski Piotr , Blay Jean-Yves , Lahat Guy , Strauss Dirk C. , Gonzalez Ricardo , Ahuja Nita , Grignani Giovanni , Quagliuolo Vittorio , Stoeckle Eberhard , De Paoli Antonino , Pillarisetty Venu G. , Nessim Carolyn , Swallow Carol J. , Bagaria Sanjay , Canter Robert , Mullen John , Gelderblom Hans J. , Pennacchioli Elisabetta , van Coevorden Frits , Cardona Kenneth , Fiore Marco , Fairweather Mark , Gronchi Alessandro
Published: April 2023

Supplementary Figure 2
Figure S2 from Validation of a Ductal Carcinoma In Situ Biomarker Profile for Risk of Recurrence after Breast-Conserving Surgery with and without Radiotherapy
Authors: Weinmann Sheila , Leo Michael C. , Francisco Melanie , Jenkins Charisma L. , Barry Todd , Leesman Glen , Linke Steven P. , Whitworth Pat W. , Patel Rakesh , Pellicane James , Wärnberg Fredrik , Bremer Troy
Published: April 2023

Association of DS and clinicopathologic factors and treatment with ipsilateral breast event risks, forest plot of a multivariate analysis